Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × CBLB502 × Clear all
NCT01527136 2022-07-22

Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Roswell Park Cancer Institute

Phase 1 Completed
25 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡